| Abstract | Olanzapine is a safely and comprehensively applicable atypical antipsychotic drug, for the treatment of schizophrenia, and of the mild to sever maniac episode. In our case study we describe the appearance of akathisia next to olanzapine therapy in the case of a 65 years old woman, and an overview of the literature have reference to adverse events of olanzapine. |
| Authors | Zoltán Makkos, Andrea Csonka
(Affiliation: National Institute for Psychiatry and Neurology, Budapest, Hungary.)
|
| Journal | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület lapja = official journal of the Hungarian Association of Psychopharmacology
(Neuropsychopharmacol Hung)
Vol. 8
Issue 4
Pg. 215-7
(Dec 2006)
ISSN: 1419-8711 Hungary |
| Vernacular Title | Olanzapin kezelés mellett jelentkezö akathisia. |
| PMID | 17211056
(Publication Type: Case Reports, English Abstract, Journal Article)
|
| Chemical References |
- Anticonvulsants
- Antipsychotic Agents
- Azabicyclo Compounds
- Benzodiazepines
- Hypnotics and Sedatives
- Piperazines
- olanzapine
- Clonazepam
- zopiclone
|
| Topics |
- Aged
- Akathisia, Drug-Induced
(etiology)
- Anticonvulsants
(administration & dosage)
- Antipsychotic Agents
(administration & dosage, adverse effects)
- Azabicyclo Compounds
- Benzodiazepines
(administration & dosage, adverse effects)
- Clonazepam
(administration & dosage)
- Drug Therapy, Combination
- Female
- Humans
- Hypnotics and Sedatives
(administration & dosage)
- Patient Admission
- Piperazines
(administration & dosage)
- Schizophrenia
(drug therapy)
- Treatment Outcome
|
